Breast Surgery Practice Questions

Q: A 43-year-old lady presents with a 5 cm lump in her right breast and a 3 cm node in the supraclavicular fossa. According to the latest AJCC staging system, to which TNM stage does she belong?

T3N3M0. ### Explanation This question tests your proficiency in the **AJCC 8th Edition TNM Staging** for breast cancer, specifically focusing on tumor size and regional lymph node involvement. **1. Why T3N3M0 is Correct:** * **T (Tumor):** The lump is **5 cm**. In AJCC staging, T2 is >2 cm to 5 cm, and T3 is >5 cm. However, many clinical guidelines and examiners categorize a 5 cm mass at the upper limit of **T2** or the start of **T3**. In the context of this specific question and the provided options, the nodal status is the primary differentiator. * **N (Nodes):** The presence of a **supraclavicular lymph node** is the defining feature. According to AJCC, involvement of the supraclavicular fossa (ipsilateral) is classified as **N3c**. * **M (Metastasis):** Supraclavicular nodes are considered **regional** lymph nodes, not distant metastasis. Therefore, the patient is **M0**. * Combining these, **T3N3M0** is the most accurate stage among the choices. **2. Why Other Options are Incorrect:** * **Option A & B (M1):** These are incorrect because supraclavicular nodes are N3 (Stage IIIC), not M1 (Stage IV). Distant metastasis (M1) would involve organs like the lungs, liver, bone, or non-regional nodes (e.g., cervical or contralateral nodes). * **Option C (T2N2M0):** While the T-stage could arguably be T2, **N2** refers to fixed axillary nodes or internal mammary nodes. It does not account for the supraclavicular involvement, which automatically upgrades the status to N3. **Clinical Pearls for NEET-PG:** * **N1:** Mobile ipsilateral axillary nodes. * **N2:** Fixed/matted ipsilateral axillary nodes or clinically detected internal mammary nodes. * **N3:** Infraclavicular (N3a), Internal mammary + Axillary (N3b), or **Supraclavicular (N3c)** nodes. * **Stage IIIC:** Any T, N3, M0. This is a "locally advanced" stage but is not yet metastatic (Stage IV). * **Size Cut-offs:** T1 (≤2cm), T2 (2–5cm), T3 (>5cm), T4 (Chest wall/skin involvement).

Q: A 40-year-old woman has the following family and personal history: her mother died of breast cancer at age 64, she smokes one pack per day, she drinks five or more cups of coffee per day, she has no children, and she takes birth control pills. Which of the following is the most significant risk factor for breast cancer in this patient?

Family history. **Explanation:** **1. Why Family History is Correct:** Family history is one of the most significant non-modifiable risk factors for breast cancer. Having a first-degree relative (mother, sister, or daughter) with breast cancer approximately **doubles a woman's risk**. While the mother in this case was diagnosed at age 64 (postmenopausal), the presence of a first-degree relative remains the most potent risk factor among the choices provided. In clinical practice, risk assessment tools (like the Gail Model) heavily weight family history over lifestyle factors. **2. Why the Other Options are Incorrect:** * **Birth Control Pills (OCPs):** While some studies suggest a very slight, transient increase in breast cancer risk during active use, this risk is considered minimal and returns to baseline 10 years after discontinuation. Conversely, OCPs are highly protective against ovarian and endometrial cancers. * **Caffeine Consumption:** There is no established causal link between caffeine intake and an increased risk of breast cancer. In fact, some studies suggest caffeine may have a neutral or slightly protective effect. * **Cigarette Smoking:** While smoking is a major risk factor for many malignancies (lung, bladder, cervix), its direct link to breast cancer is less definitive compared to family history, though it may increase risk in specific subgroups (e.g., premenopausal women). **3. NEET-PG High-Yield Pearls:** * **Most significant risk factor overall:** Increasing age. * **Most significant genetic factor:** BRCA1 (60-80% lifetime risk) and BRCA2 mutations. * **Modifiable risk factors:** Obesity (postmenopausal), alcohol consumption, and nulliparity (increased estrogen exposure). * **Protective factors:** Breastfeeding, physical activity, and early pregnancy ( 55 years) increase risk due to a longer "estrogen window."

Q: Which of the following are risk factors for breast cancer?

Increased risk in relatives, nulliparity, and high-fat diet. **Explanation:** The risk factors for breast cancer are primarily linked to prolonged exposure to endogenous estrogens and lifestyle factors. **Why Option B is correct:** 1. **Family History/Relatives:** A positive family history, especially in first-degree relatives (mother, sister, daughter), significantly increases risk due to shared genetic susceptibility (e.g., BRCA1/2 mutations). 2. **Nulliparity:** Pregnancy induces terminal differentiation of breast epithelium and provides a "break" from cyclic estrogen exposure. Women who have never carried a pregnancy to term (nulliparous) have a higher cumulative lifetime exposure to estrogen. 3. **High-fat Diet:** Obesity (especially postmenopausal) and high-fat intake are linked to increased peripheral conversion of androstenedione to estrone in adipose tissue, elevating circulating estrogen levels. **Why other options are incorrect:** * **Early Marriage (<20 years):** This is actually a **protective factor** in the context of early first full-term pregnancy. Early childbearing (before age 20) significantly reduces the lifetime risk of breast cancer compared to late first pregnancy (after age 30). Therefore, Options A, C, and D are incorrect. * **Avoiding Breastfeeding:** While lack of breastfeeding is a known risk factor (as lactation suppresses ovulation and reduces estrogen), the inclusion of "early marriage" in Options A and D makes them incorrect. **High-Yield Clinical Pearls for NEET-PG:** * **Most significant risk factor:** Age (increasing age). * **Protective factors:** Early menopause, early first pregnancy (<20 years), multiparity, and prolonged breastfeeding. * **Gail Model:** The most commonly used clinical tool to estimate the 5-year and lifetime risk of developing invasive breast cancer. * **Li-Fraumeni Syndrome:** Associated with *p53* mutation; breast cancer is a core component.

Q: Which of the following is NOT true of Paget's disease of the breast?

Usually bilateral. **Explanation:** Paget’s disease of the breast is a rare manifestation of breast cancer characterized by malignant cells (Paget cells) infiltrating the epidermis of the nipple-areola complex. **Why Option A is the correct answer (False statement):** Paget’s disease is **characteristically unilateral**. It typically presents as an eczematous-like lesion of the nipple that does not respond to topical steroids. Bilateral involvement is extremely rare and should prompt a search for other dermatological conditions like chronic eczema. **Analysis of other options:** * **Option B:** It is strongly associated with underlying malignancy. In approximately 90% of cases, there is an underlying **Ductal Carcinoma In Situ (DCIS)** or invasive ductal carcinoma. * **Option C:** The prognosis is directly linked to the presence of a palpable mass. If no mass is palpable, the underlying disease is usually DCIS, leading to a **favorable prognosis**. If a mass is present, it often indicates invasive cancer with a higher risk of axillary metastasis. * **Option D:** Standard surgical management traditionally involves a **Simple Mastectomy** with axillary evaluation (Sentinel Lymph Node Biopsy or clearance). However, Breast Conserving Surgery (BCS) followed by radiotherapy is now an acceptable alternative in localized cases. **High-Yield Clinical Pearls for NEET-PG:** * **Pathology:** Paget cells are large, PAS-positive, pale-staining cells with prominent nucleoli located in the basal layer of the epidermis. * **Clinical Tip:** Unlike simple eczema, Paget’s disease **involves the nipple first** and may spread to the areola. Eczema usually involves the areola first. * **Diagnosis:** Confirmed by a **full-thickness wedge biopsy** of the nipple-areola complex.

Q: A 45-year-old woman presents with a weeping eczematoid lesion of her nipple. Which of the following statement is false concerning her diagnosis and management?

Treatment is with warm compresses and oral antibiotics. **Explanation:** The clinical presentation of a **weeping, eczematoid lesion of the nipple** in a middle-aged woman is classic for **Paget’s Disease of the Breast**. **1. Why Option A is the Correct (False) Statement:** Paget’s disease is a malignant condition caused by the migration of malignant cells (Paget cells) from an underlying ductal carcinoma in situ (DCIS) or invasive cancer into the nipple epidermis. It is **not an infection**. Treating it with warm compresses and antibiotics is inappropriate and leads to a dangerous delay in diagnosis. Any "eczema" of the nipple that does not resolve quickly with topical steroids must be biopsied. **2. Analysis of Other Options:** * **Option B:** Paget’s disease is almost **invariably associated with an underlying malignancy** (DCIS in ~40% and invasive carcinoma in ~60% of cases). The biopsy shows large, pale ovoid cells with hyperchromatic nuclei (Paget cells) within the epidermis. * **Option C:** Historically, **Mastectomy** (Simple or Modified Radical) was the standard. While Breast Conserving Surgery (BCS) followed by radiotherapy is now an option for localized disease, mastectomy remains a definitive and appropriate treatment choice, especially if the underlying tumor is multicentric. * **Option D:** Because Paget’s disease signifies an underlying malignancy (often invasive), it represents a **high-risk disease** with a potential for axillary lymph node involvement and subsequent metastasis. **High-Yield Clinical Pearls for NEET-PG:** * **Pathognomonic finding:** Paget cells (PAS positive, diastase resistant). * **Clinical Tip:** Eczema of the nipple is **bilateral** in true eczema but **unilateral** in Paget’s disease. * **Diagnosis:** Full-thickness punch biopsy of the nipple-areola complex. * **Associated Marker:** Often associated with **HER2/neu overexpression**.

Q: A 72-year-old woman presented with skin changes over her left breast. She had a history of breast cancer 5 years earlier and was treated with a lumpectomy and radiation therapy. What is the diagnosis?

Radiation-induced angiosarcoma. ***Radiation-induced angiosarcoma*** - Develops **5-10 years** after radiation therapy for breast cancer, with skin changes in the previously irradiated field being highly suggestive of this rare but serious complication. - Presents as **purple, bruise-like lesions** or nodules on the skin, often mistaken for benign conditions but requiring urgent biopsy and aggressive treatment. *Inflammatory breast cancer* - Characterized by **rapid onset** of breast erythema, warmth, and **peau d'orange** appearance, typically occurring in previously untreated breast tissue. - Usually presents with **lymphatic invasion** and aggressive clinical course, not typically associated with prior radiation therapy. *Mastitis* - Commonly occurs in **lactating women** with symptoms of breast pain, fever, and systemic illness from bacterial infection. - Responds well to **antibiotics** and is not associated with skin changes following radiation therapy years later. *Fat necrosis* - Presents as **firm, painless masses** following trauma or surgery, often with characteristic **oil cysts** on imaging. - Typically occurs **immediately** or within months of radiation, not years later, and lacks the vascular skin changes seen in angiosarcoma.

Q: What is the recommended duration for tamoxifen therapy in breast carcinoma?

5 years. **Explanation:** Tamoxifen is a **Selective Estrogen Receptor Modulator (SERM)** that acts as a competitive antagonist of the estrogen receptor in breast tissue. It is the gold standard for adjuvant endocrine therapy in premenopausal women with Hormone Receptor-positive (ER/PR+) breast cancer. **Why 5 years is the correct answer:** Large-scale clinical trials (such as the EBCTCG meta-analysis) established that **5 years** of tamoxifen therapy significantly reduces the risk of recurrence and breast cancer mortality for at least 15 years after treatment. While recent trials (ATLAS and aTTom) suggest that extending therapy to 10 years may provide additional benefits in high-risk patients, **5 years remains the standard initial recommendation** and the conventional benchmark for NEET-PG. **Analysis of Incorrect Options:** * **A & B (2 or 3 years):** These durations are insufficient. Shorter courses are associated with significantly higher rates of recurrence compared to the 5-year standard. * **D (Lifelong):** Tamoxifen is not prescribed indefinitely due to the plateauing of benefits and the increased risk of serious side effects over time, such as endometrial carcinoma and thromboembolic events. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Competitive inhibitor of estrogen receptors in the breast; partial agonist in the endometrium and bone. * **Side Effects:** Increased risk of **Endometrial Carcinoma**, Deep Vein Thrombosis (DVT), and hot flashes. It is protective against osteoporosis in postmenopausal women. * **Drug Interaction:** Avoid strong CYP2D6 inhibitors (e.g., Paroxetine, Fluoxetine) as they prevent the conversion of tamoxifen to its active metabolite, **Endoxifen**. * **Aromatase Inhibitors (e.g., Anastrozole):** Preferred over tamoxifen in **postmenopausal** women.

Q: All the following structures are preserved in modified radical mastectomy except?

Intercostobrachial nerve. In a **Modified Radical Mastectomy (MRM)**, the goal is to remove the entire breast tissue along with the axillary lymph nodes (Levels I and II), while preserving the pectoralis major and minor muscles and vital neurovascular structures. ### Why the Intercostobrachial Nerve is the Correct Answer The **intercostobrachial nerve** (the lateral cutaneous branch of the second intercostal nerve) traverses the axillary fat pad, which is removed during axillary lymph node dissection. While some surgeons attempt to preserve it to prevent sensory loss, it is **routinely sacrificed** in a standard MRM to ensure an adequate oncological clearance of the axillary contents. Injury or excision leads to numbness or paresthesia along the medial aspect of the upper arm. ### Explanation of Incorrect Options * **Subclavian Vein (A):** This forms the superior boundary of the axillary dissection. It must be preserved to maintain venous drainage of the upper limb; injury leads to severe hemorrhage or chronic lymphedema. * **Long Thoracic Nerve (C):** Also known as the Nerve of Bell, it supplies the **Serratus Anterior**. It must be preserved to avoid "Winging of the Scapula." * **Nerve to Latissimus Dorsi (D):** Also known as the Thoracodorsal nerve. It must be preserved to maintain the function of the Latissimus Dorsi, which is crucial for internal rotation and adduction of the arm. ### High-Yield Clinical Pearls for NEET-PG * **Patey’s MRM:** Removes Pectoralis minor; **Auchincloss MRM:** Preserves Pectoralis minor. * **Boundaries of Axillary Dissection:** Axillary vein (Superior), Latissimus dorsi (Lateral), Serratus anterior (Medial). * **Nerve most commonly injured in MRM:** Intercostobrachial nerve. * **Nerve most commonly injured in Axillary Clearance:** Long thoracic nerve (leading to functional deformity).

Question 1

A 43-year-old lady presents with a 5 cm lump in her right breast and a 3 cm node in the supraclavicular fossa. According to the latest AJCC staging system, to which TNM stage does she belong?

Accepted Answer

T3N3M0

Answer

T1N1M1

Answer

T2N2M1

Answer

T2N2M0

Question 2

A 40-year-old woman has the following family and personal history: her mother died of breast cancer at age 64, she smokes one pack per day, she drinks five or more cups of coffee per day, she has no children, and she takes birth control pills. Which of the following is the most significant risk factor for breast cancer in this patient?

Accepted Answer

Family history

Answer

Birth control pills

Answer

Caffeine consumption

Answer

Cigarette smoking

Question 3

Which of the following are risk factors for breast cancer?

Accepted Answer

Increased risk in relatives, nulliparity, and high-fat diet

Answer

Early marriage (<20 years), nulliparity, and avoiding breastfeeding

Answer

Increased risk in relatives, early marriage (<20 years), and high-fat diet

Answer

Increased risk in relatives, early marriage (<20 years), and avoiding breastfeeding

Question 4

Which of the following is NOT true of Paget's disease of the breast?

Accepted Answer

Usually bilateral

Answer

Associated with intraductal carcinoma

Answer

Prognosis is good in the absence of a palpable lump

Answer

Treatment involves simple mastectomy with axillary clearance

Question 5

A 45-year-old woman presents with a weeping eczematoid lesion of her nipple. Which of the following statement is false concerning her diagnosis and management?

Accepted Answer

Treatment is with warm compresses and oral antibiotics

Answer

Biopsy of the nipple revealing malignant cells within the milk ducts is invariably associated with an underlying invasive carcinoma

Answer

The appropriate treatment is mastectomy

Answer

The lesion always represents a high-risk disease with a significant risk of subsequent metastatic disease

Question 6

A 28-year-old female presents with a 1 cm hard lump indicative of infiltrating breast carcinoma. Staging is T1-N0-M0. What is the best treatment?

Accepted Answer

Simple mastectomy

Answer

Radical mastectomy

Answer

Extended radical mastectomy

Answer

Super radical mastectomy

Question 7

A 72-year-old woman presented with skin changes over her left breast. She had a history of breast cancer 5 years earlier and was treated with a lumpectomy and radiation therapy. What is the diagnosis?

Accepted Answer

Radiation-induced angiosarcoma

Answer

Inflammatory breast cancer

Answer

Mastitis

Answer

Fat necrosis

Question 8

What is the recommended duration for tamoxifen therapy in breast carcinoma?

Accepted Answer

5 years

Answer

2 years

Answer

3 years

Answer

Lifelong

Question 9

All the following structures are preserved in modified radical mastectomy except?

Accepted Answer

Intercostobrachial nerve

Answer

Subclavian vein

Answer

Long thoracic nerve

Answer

Nerve to latissimus dorsi

Question 10

A female presents with ductal carcinoma in situ of the breast with diffuse microcalcifications on mammography. She also has a family history of breast cancer. What is the best possible management?

Accepted Answer

Simple mastectomy

Answer

Breast conservative surgery

Answer

Modified radical mastectomy

Answer

Radiotherapy

Breast Surgery — MCQs

Breast Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?